Up next
- Merck, Moderna Stocks Soar After Melanoma Trial Success
- SK Hynix Announces $29 Billion Share Buyback Plan
- When the Bond Market Speaks, People Listen, TD's Goldberg Says
- Merck, Moderna Melanoma Vaccine Study Succeeds
- September Rate Hike Isn't Too Bad of an Idea, Bullard Says
- US Treasury Increasing Long-Dated Buyback Cap to at Least $4 Billion
